Dental Bone Graft Substitutes Global Market Report 2024

The dental bone graft substitutes market size has grown strongly in recent years. It will grow from $3.86 billion in 2023 to $4.15 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The growth observed in the historical period can be attributed to the increasing number of dental procedures, a rise in dental restoration needs, the expanding aging population, an increase in cosmetic dentistry procedures, a preference for minimally invasive dentistry, and the growing demand from patients for aesthetic solutions.

The dental bone graft substitutes market size is expected to see strong growth in the next few years. It will grow to $5.27 billion in 2028 at a compound annual growth rate (CAGR) of 6.2%. The anticipated growth in the forecast period can be attributed to the growing emphasis on preventive dentistry, an increasing demand for implant dentistry, a focus on bioactive and biomimetic materials, the expansion of dental tourism, and a shift towards holistic and patient-centric dentistry. Significant trends expected in the forecast period include the application of digital impression technology in cementation, the development of color-matching technology in resin cements, the introduction of fast-setting and high-viscosity cements, an emphasis on adhesive cements with low post-operative sensitivity, and a focus on self-etching and selective etching techniques.

The anticipated increase in the prevalence of dental disorders is set to drive the growth of the dental bone graft substitute market. Dental disorders encompass various medical conditions affecting the oral cavity, including the teeth, gums, tongue, lips, cheeks, palate, and other structures. Dental bone graft substitutes play a crucial role in treating these disorders by addressing bone deficiencies in the jaw or supporting dental implant placement. This involves transplanting bone tissue to the affected area to provide a structure for new bone growth. According to the World Health Organization's November 2022 report, around 3.55 billion individuals worldwide suffer from oral disorders, marking an increase of 1 billion from 2021. Thus, the rising prevalence of dental disorders is a key driver for the growth of the dental bone graft substitute market.

The growing elderly population is expected to propel the dental bone graft substitute market forward. The elderly population comprises individuals who are advanced in age or considered seniors. Dental bone graft substitutes play a crucial role in addressing the specific dental needs of the elderly, contributing to improved oral health and overall quality of life for aging individuals. As of July 2023, a report by Age UK, a UK-based registered charity, stated that England has 11 million individuals aged over 65, projected to increase by 10% in the next five years and by 32% by 2043. The population aged 85 and above is expected to rise by 8.2% in the next five years and by 62.7% by 2043, reaching 2.8 million. Therefore, the growing elderly population is a significant factor driving the growth of the dental bone graft substitute market.

The high cost of dental bone graft substitutes acts as a significant restraint on the growth of the market. The cost of these substitutes can vary significantly based on factors such as the specific product, brand, and geographic region. Some graft materials may be more expensive due to factors such as manufacturing processes, purity, and regulatory approvals. For instance, as of September 2021, bone grafting for dental purposes can cost between $300 and $800 for a single implant, according to Omega Dental, a US-based dental care provider. This high cost presents a hindrance to the growth of the dental bone graft substitute market.

Major companies in the dental bone graft substitute market are focusing on developing innovative products such as regenerOss CC allograft particulate and regenerOss bone graft plug to enhance their services. RegenerOss CC allograft particulate is a dental bone graft substitute material containing a natural blend of cortical and cancellous bone particles to promote bone regeneration in the oral cavity. RegenerOss bone graft plug is a solution for filling extraction sockets and periodontal defects. For example, in April 2023, ZimVie Inc., a US-based medical instrument manufacturing company, introduced RegenerOss CC Allograft Particulate and RegenerOss Bone Graft Plug, designed for minimally invasive procedures that can be performed in an office setting. These products, made from bovine bone, offer a safe and effective way to repair or reconstruct the jaw, applicable in various dental applications.

In January 2021, Dentsply Sirona, a US-based dental equipment manufacturing company, acquired Datum Dental Ltd. for an undisclosed amount. This acquisition is part of Dentsply Sirona's efforts to provide innovative solutions in dentistry, empowering dental professionals to deliver better care to patients. Datum Dental Ltd. is an Israel-based manufacturer specializing in dental regeneration products and dental bone graft substitute materials.

Major companies operating in the dental bone graft substitutes market report are Johnson and Johnson Services Inc., Stryker Corporation, Medtronic PLC, Zimmer Biomet Holdings Inc., Smith and Nephew PLC, Dentsply Sirona, Straumann Group, ZimVie Inc., Wright Medical Group N.V., LifeNet Health, RTI Surgicals Inc., Dentium Co. Ltd., Orthofix Medical Inc., BioHorizons Inc., Keystone Dental Inc., Geistlich Pharma AG, MIS Implants Technologies Ltd., Sunstar Group, Collagen Matrix Inc., OsteoMed LLC, Ace Surgical Supply Co. Inc., Salvin Dental Specialties Inc., Osteogenics Biomedical Inc., Botiss biomaterials GmbH, Curasan Inc., Novabone Products LLC, Biomatlante S.A, Carmell Therapeutics Corp., Neobiotech Co. Ltd., Silfradent S.r.l.

North America was the largest region in the dental bone graft substitutes market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the dental bone graft substitutes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the dental bone graft substitutes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Dental bone graft substitutes are biocompatible substances utilized in oral and maxillofacial surgery to facilitate bone regeneration and restore lost or damaged bone tissue in the jaw or oral cavity. These substitutes are typically employed when a patient lacks sufficient natural bone volume or density, often due to tooth extraction, periodontal disease, trauma, or other dental conditions.

The primary types of dental bone graft substitutes include xenograft, allograft, autograft, and others. A xenograft dental bone graft substitute encompasses various materials, such as hydroxyapatite, tricalcium phosphate, calcium phosphate, and others. These materials operate through mechanisms such as osteoconduction, osteoinduction, osteogenesis, and osteopromotion. They find applications in ridge augmentation, sinus lift, socket preservation, and addressing periodontal defects. End users of these substitutes include hospitals, dental clinics, and other healthcare facilities.

The dental bone graft substitutes market research report is one of a series of new reports that provides dental bone graft substitutes market statistics, including dental bone graft substitutes industry global market size, regional shares, competitors with dental bone graft substitutes market share, detailed dental bone graft substitutes market segments, market trends and opportunities, and any further data you may need to thrive in the dental bone graft substitutes industry. This dental bone graft substitutes market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dental bone graft substitutes market consists of sales of demineralized bone matrix (DBM), ceramic-based bone grafts, calcium sulfate bone grafts, and synthetic bone graft substitutes. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.